Keyword search (3,619 papers available)


Oriented attachment by enantioselective facet recognition in millimeter-sized gypsum crystals.

Author(s): Viedma C, Cuccia LA, McTaggart A, Kahr B, Martin AT, McBride JM, Cintas P

Chem Commun (Camb). 2016 Sep 22;52(78):11673-11676 Authors: Viedma C, Cuccia LA, McTaggart A, Kahr B, Martin AT, McBride JM, Cintas P

Article GUID: 27722508

Directing the Viedma ripening of ethylenediammonium sulfate using "Tailor-made" chiral additives.

Author(s): Nguyen TP, Cheung PS, Werber L, Gagnon J, Sivakumar R, Lennox C, Sossin A, Mastai Y, Cuccia LA

Chem Commun (Camb). 2016 Oct 18;52(85):12626-12629 Authors: Nguyen TP, Cheung PS, Werber L, Gagnon J, Sivakumar R, Lennox C, Sossin A, Mastai Y, Cuccia LA

Article GUID: 27722259

A NIR-responsive azobenzene-based supramolecular hydrogel using upconverting nanoparticles.

Author(s): Mandl GA, Rojas-Gutierrez PA, Capobianco JA

Chem Commun (Camb). 2018 Jun 05;54(46):5847-5850 Authors: Mandl GA, Rojas-Gutierrez PA, Capobianco JA

Article GUID: 29726556

Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery

Author(s): Dajana Vuckovic

This Feature Article highlights some of the key challenges within the field of metabolomics and examines what role separation and analytical sciences can play to improve the use of metabolomics in biomarker discovery and personalized medicine. Recent progre...

Article GUID: 29888773


Title:Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery
Authors:Dajana Vuckovic
Link:https://pubmed.ncbi.nlm.nih.gov/29888773/
DOI:10.1039/c8cc02592d
Category:Chem Commun (Camb)
PMID:29888773
Dept Affiliation: CHEMBIOCHEM
1 Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec H4B 1R6, Canada. dajana.vuckovic@concordia.ca.

Description:

This Feature Article highlights some of the key challenges within the field of metabolomics and examines what role separation and analytical sciences can play to improve the use of metabolomics in biomarker discovery and personalized medicine. Recent progress in four key areas is highlighted: (i) improving metabolite coverage, (ii) developing accurate methods for unstable metabolites including in vivo global metabolomics methods, (iii) advancing inter-laboratory studies and reference materials and (iv) improving data quality, standardization and quality control of metabolomics studies.